|4Jun 22, 8:12 PM ET

Koppel Adam 4

4 · Foghorn Therapeutics Inc. · Filed Jun 22, 2023

Insider Transaction Report

Form 4
Period: 2023-06-21
Koppel Adam
Director
Transactions
  • Award

    Stock Option (right to buy)

    2023-06-21+16,00016,000 total
    Exercise: $8.70From: 2024-06-21Exp: 2033-06-20Common Stock (16,000 underlying)

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT